The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy; Use as a Single Agent in Susceptible Patients; Techniques Used to Identify Susceptible Patients
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-61779-270-0_15
PubMed Identifier: 21870265
Publication URI: http://europepmc.org/abstract/MED/21870265
Type: Book Chapter
Book Title: Poly(ADP-ribose) Polymerase - Methods and Protocols (2011)
Page Reference: 239-266
ISSN: 1064-3745